nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA2—islet of Langerhans—gestational diabetes	0.0542	0.106	CbGeAlD
Lithium—GSK3B—embryo—gestational diabetes	0.0514	0.101	CbGeAlD
Lithium—GSK3A—islet of Langerhans—gestational diabetes	0.0462	0.0906	CbGeAlD
Lithium—IMPA1—head—gestational diabetes	0.0354	0.0693	CbGeAlD
Lithium—GSK3B—uterus—gestational diabetes	0.0347	0.068	CbGeAlD
Lithium—IMPA2—adipose tissue—gestational diabetes	0.0346	0.0677	CbGeAlD
Lithium—GSK3B—adipose tissue—gestational diabetes	0.0339	0.0665	CbGeAlD
Lithium—GSK3A—uterus—gestational diabetes	0.0302	0.0591	CbGeAlD
Lithium—GRIA3—head—gestational diabetes	0.0301	0.0589	CbGeAlD
Lithium—GSK3A—adipose tissue—gestational diabetes	0.0295	0.0578	CbGeAlD
Lithium—IMPA2—vagina—gestational diabetes	0.0287	0.0563	CbGeAlD
Lithium—GSK3B—vagina—gestational diabetes	0.0282	0.0553	CbGeAlD
Lithium—GSK3B—head—gestational diabetes	0.026	0.051	CbGeAlD
Lithium—GSK3A—vagina—gestational diabetes	0.0245	0.048	CbGeAlD
Lithium—GSK3A—Leptin signaling pathway—LEPR—gestational diabetes	0.0243	0.0496	CbGpPWpGaD
Lithium—GSK3A—head—gestational diabetes	0.0226	0.0444	CbGeAlD
Lithium—GSK3A—SREBP signalling—RBP4—gestational diabetes	0.02	0.0408	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.0195	0.0398	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.0185	0.0378	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.018	0.0368	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—LEPR—gestational diabetes	0.0179	0.0366	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—GLS2—gestational diabetes	0.0149	0.0305	CbGpPWpGaD
Lithium—GSK3B—Regulation of Androgen receptor activity—AR—gestational diabetes	0.0116	0.0236	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GGCT—gestational diabetes	0.00919	0.0188	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—LEP—gestational diabetes	0.00853	0.0174	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GGCT—gestational diabetes	0.00819	0.0167	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GLS2—gestational diabetes	0.00804	0.0164	CbGpPWpGaD
Lithium—GSK3B—Androgen receptor signaling pathway—AR—gestational diabetes	0.00764	0.0156	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GLS2—gestational diabetes	0.00716	0.0146	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.00697	0.0142	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.00678	0.0138	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00645	0.0132	CbGpPWpGaD
Lithium—GSK3B—Cardiac Progenitor Differentiation—FGF2—gestational diabetes	0.00632	0.0129	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—LEP—gestational diabetes	0.0063	0.0129	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00614	0.0125	CbGpPWpGaD
Lithium—GSK3A—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.00581	0.0119	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—NAMPT—gestational diabetes	0.00564	0.0115	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00562	0.0115	CbGpPWpGaD
Lithium—GSK3A—PI-3K cascade—FGF2—gestational diabetes	0.00523	0.0107	CbGpPWpGaD
Lithium—GSK3A—PI3K/AKT activation—FGF2—gestational diabetes	0.00511	0.0104	CbGpPWpGaD
Lithium—GSK3A—GAB1 signalosome—FGF2—gestational diabetes	0.00507	0.0103	CbGpPWpGaD
Lithium—GSK3A—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00495	0.0101	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—TNF—gestational diabetes	0.00464	0.00947	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00461	0.00942	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NAMPT—gestational diabetes	0.0044	0.00899	CbGpPWpGaD
Lithium—IMPA2—Metabolism—GCK—gestational diabetes	0.00438	0.00893	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00437	0.00893	CbGpPWpGaD
Lithium—GSK3B—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.00429	0.00876	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NAMPT—gestational diabetes	0.00392	0.00801	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00391	0.00798	CbGpPWpGaD
Lithium—IMPA1—Metabolism—GCK—gestational diabetes	0.0039	0.00796	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—FGF2—gestational diabetes	0.00387	0.00789	CbGpPWpGaD
Lithium—GSK3B—PI3K/AKT activation—FGF2—gestational diabetes	0.00377	0.00771	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—FGF2—gestational diabetes	0.00377	0.00771	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—FGF2—gestational diabetes	0.00374	0.00764	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00374	0.00764	CbGpPWpGaD
Lithium—GSK3B—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.00374	0.00763	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—FGF2—gestational diabetes	0.00368	0.00752	CbGpPWpGaD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00366	0.00747	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MBL2—gestational diabetes	0.00363	0.00741	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—FGF2—gestational diabetes	0.00352	0.00718	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—FGF2—gestational diabetes	0.0035	0.00715	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—FGF2—gestational diabetes	0.00348	0.00711	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—FGF2—gestational diabetes	0.00347	0.00708	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00342	0.00697	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00326	0.00666	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—FGF2—gestational diabetes	0.00326	0.00666	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00326	0.00666	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—FGF2—gestational diabetes	0.00323	0.0066	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.0032	0.00654	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CYP19A1—gestational diabetes	0.0032	0.00653	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—FGF2—gestational diabetes	0.00319	0.00651	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00307	0.00626	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—FGF2—gestational diabetes	0.00302	0.00616	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00289	0.0059	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.00289	0.0059	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—LEP—gestational diabetes	0.00286	0.00585	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CYP19A1—gestational diabetes	0.00285	0.00582	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—TNF—gestational diabetes	0.0028	0.00571	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00276	0.00565	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—GCK—gestational diabetes	0.00273	0.00557	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—FGF2—gestational diabetes	0.00272	0.00556	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MBL2—gestational diabetes	0.00268	0.00547	CbGpPWpGaD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.00266	0.00544	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—FGF2—gestational diabetes	0.0026	0.00531	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGF2—gestational diabetes	0.00259	0.00528	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—FGF2—gestational diabetes	0.00257	0.00525	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—FGF2—gestational diabetes	0.00256	0.00523	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00252	0.00515	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00241	0.00492	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGF2—gestational diabetes	0.00241	0.00492	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00241	0.00492	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—FGF2—gestational diabetes	0.00239	0.00488	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00237	0.00483	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGF2—gestational diabetes	0.00236	0.00481	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—ADIPOQ—gestational diabetes	0.00225	0.00459	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—FGF2—gestational diabetes	0.00223	0.00455	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGF2—gestational diabetes	0.00222	0.00453	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.00213	0.00436	CbGpPWpGaD
Lithium—GSK3A—Immune System—MBL2—gestational diabetes	0.00211	0.00431	CbGpPWpGaD
Lithium—GSK3A—Disease—RBP4—gestational diabetes	0.00197	0.00402	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00187	0.00381	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEPR—gestational diabetes	0.00179	0.00365	CbGpPWpGaD
Lithium—GSK3A—Disease—NAMPT—gestational diabetes	0.00176	0.0036	CbGpPWpGaD
Lithium—GSK3A—Disease—GCK—gestational diabetes	0.00175	0.00358	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—FGF2—gestational diabetes	0.00164	0.00335	CbGpPWpGaD
Lithium—GSK3B—Immune System—MBL2—gestational diabetes	0.00156	0.00319	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—LEP—gestational diabetes	0.00146	0.00298	CbGpPWpGaD
Lithium—GSK3B—Disease—RBP4—gestational diabetes	0.00145	0.00297	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MTNR1B—gestational diabetes	0.00141	0.00289	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—LEP—gestational diabetes	0.0014	0.00285	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RBP4—gestational diabetes	0.00138	0.00281	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEPR—gestational diabetes	0.00132	0.0027	CbGpPWpGaD
Lithium—GSK3B—Disease—NAMPT—gestational diabetes	0.0013	0.00266	CbGpPWpGaD
Lithium—GSK3B—Disease—GCK—gestational diabetes	0.0013	0.00265	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGF2—gestational diabetes	0.00127	0.00259	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—FGF2—gestational diabetes	0.00122	0.00248	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—FGF2—gestational diabetes	0.00106	0.00216	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MTNR1B—gestational diabetes	0.00104	0.00213	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBP4—gestational diabetes	0.00102	0.00208	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGF2—gestational diabetes	0.000936	0.00191	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF2—gestational diabetes	0.000899	0.00184	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF2—gestational diabetes	0.000738	0.00151	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF2—gestational diabetes	0.000681	0.00139	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—gestational diabetes	0.000645	0.00132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—gestational diabetes	0.000628	0.00128	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF2—gestational diabetes	0.000545	0.00111	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF2—gestational diabetes	0.000503	0.00103	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGF2—gestational diabetes	0.000477	0.000974	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—gestational diabetes	0.000464	0.000947	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF2—gestational diabetes	0.000352	0.00072	CbGpPWpGaD
